Kimberly Wilson

Statistics

Publications

Citations

626

H-Index

Active since

1990

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kimberly Wilson is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in fungal biochemistry, mycology, and fungal natural product biosynthesis.

Publications per year

1990–2017

Publications

Discovery of Novel Antifungal (1,3)-β- <scp>d</scp> -Glucan Synthase Inhibitors

Janet C. Onishi, M. Meinz, John R. Thompson et al. · Antimicrobial Agents and Chemotherapy · 2000 · 319 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Dennis M. Schmatz, M A Romancheck, L A Pittarelli et al. · Proceedings of the National Academy of Sciences · 1990 · 160 citations

Medicine, Infectious Diseases, Pharmacology +9

<i>SNCA</i> multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies

Janel Johnson, Stephen Hague, M Hanson et al. · Neurology · 2004 · 71 citations

Life Sciences, Genetics, Neurology +14

Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

M. Francisca Vicente, Angeles Cabello, Gonzalo Platas et al. · Journal of Applied Microbiology · 2001 · 53 citations

Life Sciences, Biology, Microbiology +17

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

Mo Yi, Julie Stromswold, Kimberly Wilson et al. · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2017 · 23 citations · Full text

Medicine, Neurology, Neuroscience +17

1–5 of 5